|Bid||228.92 x 800|
|Ask||229.07 x 900|
|Day's Range||227.10 - 239.42|
|52 Week Range||210.28 - 276.69|
|Beta (5Y Monthly)||0.71|
|PE Ratio (TTM)||18.91|
|Earnings Date||Oct 26, 2021 - Nov 01, 2021|
|Forward Dividend & Yield||7.04 (2.95%)|
|Ex-Dividend Date||May 14, 2021|
|1y Target Est||254.96|
Amgen stock dipped late Tuesday after reporting adjusted income of $4.38 per share on $6.53 billion in second-quarter sales.
The biopharma name cautioned shareholders that it's still suffering from a pandemic hangover, but investors should think bigger-picture.
View more earnings on AMGNSee more from BenzingaClick here for options trades from BenzingaAmgen Q2 Profit Falls On Five Prime Acquisition Related Write-off, Disputes IRS Claim On Owing .6B In TaxesAmgen Buys Antibody Player Focused On PSMA In .5B Deal© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.